Get the Stockscreener App
158.36
6.02%
-10.14
Pre-market:
159.84
1.48
+0.93%
Natera Inc stock is traded at $158.36, with a volume of 2.23M.
It is down -6.02% in the last 24 hours and down -5.86% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$168.50
Open:
$168.92
24h Volume:
2.23M
Relative Volume:
1.84
Market Cap:
$19.45B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-89.98
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
-9.51%
1M Performance:
-5.86%
6M Performance:
+43.48%
1Y Performance:
+134.61%
1-Day Range:
$157.51
$169.55
1-Week Range:
$157.51
$183.00
52-Week Range:
$62.96
$183.00
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
158.36 | 19.45B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Sheena Jonathan Natera Stock Sale Highlights Insider Confidence Amid Legal and Financial Milestones - HPBL
Looking Into Natera's Recent Short Interest - Benzinga
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Artemis Investment Management LLP - MarketBeat
Avanza Fonder AB Takes $1.02 Million Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera (NASDAQ:NTRA) Shares Down 2.8%Here's Why - MarketBeat
Natera guides Q4 and FY revenue above consensus - MSN
Natera (NASDAQ:NTRA) Price Target Raised to $200.00 at Guggenheim - MarketBeat
Wall Street Analysts Adjust Price Targets: Key Changes for Morgan Stanley, Bank of America, Natera and More - HPBL
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - BioSpace
Natera CEO Steve Chapman Named BioTech Innovator of the Year, Leads 20 Product Launches - StockTitan
Analysts reset Natera stock price target by 20% - TheStreet
Rockingstone Advisors LLC Buys Shares of 16,326 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Assenagon Asset Management S.A. Has $51.47 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera’s Bold Moves Stir Up Stock Market Buzz - TipRanks
Natera reports on robust product pipeline at JPM - BioWorld Online
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection - BioSpace
Natera Unveils Revolutionary Cancer Detection Tech with 92% Early-Stage Accuracy - StockTitan
Natera (NASDAQ:NTRA) Reaches New 12-Month HighTime to Buy? - MarketBeat
Natera (NASDAQ:NTRA) Shares Gap Up After Analyst Upgrade - MarketBeat
Why Natera Stocks Are Gaining Attention - TipRanks
Non-Invasive Prenatal Testing Market Top Companies Study - openPR
Natera Shatters Growth Records: Q4 Revenue Surges 52% to $472M, Oncology Tests Jump 55% - StockTitan
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024 - Business Wire
Insider Sell Alert: Daniel Rabinowitz Sells 6,223 Shares of Nate - GuruFocus.com
Harbor Capital Advisors Inc. Trims Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera's chief legal officer sells $1.09 million in stock - Investing.com India
Natera’s chief legal officer sells $1.09 million in stock By Investing.com - Investing.com Nigeria
The Analyst Verdict: Natera In The Eyes Of 14 Experts - Benzinga
Sanford C. Bernstein Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price - MarketBeat
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings - The Motley Fool
Natera, Inc. (NASDAQ:NTRA) Shares Sold by First Hawaiian Bank - MarketBeat
Natera Stock Soars to All-Time High of $175.68 By Investing.com - Investing.com Nigeria
Natera (NASDAQ:NTRA) Reaches New 1-Year HighShould You Buy? - MarketBeat
Natera Stock Soars to All-Time High of $175.68 - Investing.com India
Natera nabs ADLT status - LabPulse
Ravgen wins $57M in patent infringement suit against Natera - LabPulse
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
3,984 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Silverleafe Capital Partners LLC - MarketBeat
Natera Fails to Expand $96 Million Patent Win Over CareDx (1) - Bloomberg Law
(NTRA) Technical Data - Stock Traders Daily
Everence Capital Management Inc. Acquires Shares of 3,620 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Everence Capital Management Inc. Makes New $573,000 Investment in Natera, Inc. (NASDAQ:NTRA) - Defense World
Natera co-founder Sheena Jonathan sells $909k in stock By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $909k in stock - Investing.com
Natera Loses New Trial Bid After Winning $96M Patent Verdict - Law360
Undercovered Dozen: Natera, Lloyds Banking Group, Eaton, Primoris Services + - Seeking Alpha
Canaccord Genuity Group Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years - Yahoo Finance
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):